Prof. Alireza
Heidari
California South
University (CSU), USA
American
International Standards Institute (AISI), USA
Email:
Scholar.Researcher.Scientist@gmail.com
Qualifications
2012 Ph.D., California South University (CSU), USA
2008 M.S., Islamic Azad University (IAU), Iran
2005 B.S., Islamic Azad University (IAU), Iran
Publications
(selected)
-
A. Heidari, C.
Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles
for Eliminating Cancer Cells”, Journal of Nanomedicine Research, Volume 2,
Issue 5, 20 Pages, 2015.
-
A. Heidari, C.
Brown, “Study of Surface Morphological, Phytochemical and Structural
Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”, International
Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Pages
15–19, 2015.
-
A. Heidari,
“Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’
Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and
Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
-
A. Heidari, “Study
of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds
between Peptide Chains and Transition from Helix Structure to Random Coil
Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5:
e146, 2016.
-
A. Heidari,
“Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and
Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J
Bioanal Biomed 8: e135, 2016.
-
A. Heidari,
“Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium
Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs
for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple
Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016.
-
A. Heidari,
“Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer
(Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon
Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7:
e112, 2016.
-
A. Heidari, “A
Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride
Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal
Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr
Commun 2: 1, 2016.
-
A. Heidari,
“Combined Theoretical and Computational Study of the Belousov–Zhabotinsky
Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine,
Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as
Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
-
A. Heidari, “Ab
Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding
Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO)
Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic
Discov 6: e144, 2016.
-
A. Heidari,
“Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in
Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic
Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”,
J Glycobiol 5: e111, 2016.
-
A. Heidari,
“Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs
Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong
(SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016.
-
A. Heidari, “An
Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes
in Nucleic Acids”, Austin J Anal Pharm Chem. 3(1): 1058, 2016.
-
A. Heidari, C.
Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC
Nanocomposites”, Nano Res Appl. 2: 1, 2016.
-
A. Heidari, C.
Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric
Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced
Chemistry, 4 (1) 5–9, 2016.
-
A. Heidari,
“Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship
(QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as
Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano
Drugs”, J Integr Oncol 5: e110, 2016.
-
A. Heidari, “A
Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure
(Chromatographic) Retention Relationships (QSRR) Models for the Prediction of
Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J
Pharmacovigil 4: e161, 2016.
-
A. Heidari, “A
Gastrointestinal Study on Linear and Non–Linear Quantitative Structure
(Chromatographic) Retention Relationships (QSRR) Models for Analysis
5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under
Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
-
A. Heidari, “A
Successful Strategy for the Prediction of Solubility in the Construction of
Quantitative Structure–Activity Relationship (QSAR) and Quantitative
Structure–Property Relationship (QSPR) under Synchrotron Radiations Using
Genetic Function Approximation (GFA) Algorithm”, J Mol Biol Biotechnol 1: 1,
2016.
-
A. Heidari,
“Computational Study on Molecular Structures of C20, C60, C240, C540, C960,
C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using
Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
-
A. Heidari, “Graph
Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene
Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide
Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride
Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J Appl
Computat Math 5: e143, 2016.
-
A. Heidari,
“Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and
Quantitative Structure–Property Relationship (QSPR) under Synchrotron
Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in
Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm”,
Insight Pharm Res. 1: 1, 2016.
-
A. Heidari,
“Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of
Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules
for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60,
(p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] Nano
Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
-
A. Heidari, “Study
of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety
and Efficacy of Olympiadane Nanomolecules as Agent for Cancer
Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy
and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs 6: e154.
-
A. Heidari,
“Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General
Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using
Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84,
Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24,
Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters”, J
Surgery Emerg Med 1: 21, 2017.
Profile
Details
http://calsu.us/index.php/member/prof-dr-alireza-heidari/